Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$297.45(as of May 22, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$297.45
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,500
CountyUSA
Market Cap$39,713.3M
EBIDTA806.9M
10-Day Moving Average292.58
P/E Ratio71.23
20-Day Moving Average296.81
Forward P/E Ratio31.85
50-Day Moving Average310.32
Earnings per Share3.99
200-Day Moving Average388.35
Profit Margin17.65%
RSI47.00
Shares Outstanding133.5M
ATR10.37
52-Week High495.55
Volume681,300
52-Week Low284.28
Book Value1,075.4M
P/B Ratio38.23
Upper Keltner320.13
P/S Ratio9.59
Lower Keltner273.49
Debt-to-Equity Ratio320.13
Next Earnings Date07/29/2026
Cash Surplus361.3M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.
Alnylam Pharmaceuticals Inc In Our Stock Scanner
As of May 22, 2026
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.